NAMED PATIENT PROGRAM USE OF PEDMARK® TO REDUCE THE RISK OF CISPLATIN-INDUCED OTOTOXICITY IN PEDIATRIC PATIENTS WITH VARIED SOLID TUMORS

Sadeleştirilmiş öğe sayfası
dc.contributor.authorTanaka, Ryuma
dc.contributor.authorSullivan, Michael
dc.contributor.authorCanpolat, Cengiz
dc.contributor.authorJohnston, Robert
dc.contributor.authorAtaseven, Eda
dc.contributor.authorAtes, Dilvin Celik
dc.contributor.authorDuncan, Catriona
dc.contributor.authorJorgensen, Mette
dc.contributor.authorMccarthy, Anthony
dc.contributor.authorMurphy, Dermot
dc.contributor.authorStorck, Simone
dc.contributor.authorOpocher, Enrico
dc.contributor.authorUnal, Emel Cabi
dc.contributor.authorBrock, Penelope
dc.contributor.authorBhattacharya, Ananya
dc.contributor.authorMorgan, Allison
dc.contributor.authorBaskin\\-Bey, Edwina
dc.date.accessioned2025-10-16T15:14:19Z
dc.date.issued2023
dc.identifier.otherWOS:001183650902072
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/6130
dc.publisherWILEY
dc.sourcePEDIATRIC BLOOD \& CANCER
dc.titleNAMED PATIENT PROGRAM USE OF PEDMARK® TO REDUCE THE RISK OF CISPLATIN-INDUCED OTOTOXICITY IN PEDIATRIC PATIENTS WITH VARIED SOLID TUMORS
dc.typeMeeting Abstract

Dosyalar

Koleksiyonlar

WOS